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        Introduction 
  Synaptic vesicles are transported to the presynaptic plasma 
membrane where Ca 
2+   channels are located. Depolarization in-
duces Ca 
2+   infl  ux into the cytosol of nerve terminals through the 
Ca 
2+   channels, and this Ca 
2+   infl  ux initiates the fusion of the 
vesicles with the plasma membrane, fi  nally leading to exocyto-
sis of neurotransmitters (  S  ü  dhof, 2000  ). Soluble SNAREs are 
essential for the synaptic vesicle exocytosis (  Sutton et al., 1998  ; 
  Weber et al., 1998  ;   Weis and Scheller, 1998  ;   Jahn and S  ü  dhof, 
1999  ;   Jahn and Scheller, 2006  ). Synaptic vesicles are endowed 
with vesicle-associated membrane protein 2 (VAMP-2) as a ve-
sicular SNARE, whereas the presynaptic plasma membrane is 
endowed with syntaxin-1 and SNAP-25 as target SNAREs. 
VAMP-2 interacts with SNAP-25 and syntaxin-1 to form a sta-
ble SNARE complex (  Trimble et al., 1988  ;   Bennett et al., 1992  ; 
  S  ö  llner et al., 1993  ;   Chen and Scheller, 2001  ). The formation of 
the SNARE complex brings synaptic vesicles and the plasma 
membrane into close apposition and provides the energy that 
drives the mixing of the two lipid bilayers (  Weber et al., 1998  ; 
  Chen et al., 1999  ). 
  Tomosyn is a syntaxin-1  –  binding protein that we origi-
nally identifi  ed previously (  Fujita et al., 1998  ). Tomosyn con-
tains a large N-terminal domain with a WD-40 repeat domain 
and a C-terminal domain homologous to VAMP-2. The large 
N-terminal region of tomosyn shares similarity to the   Drosophila 
melanogaster   tumor suppressor lethal giant larvae (Lgl), the 
mammalian homologues M-Lgl1 and M-Lgl2, and the yeast 
proteins Sro7p and Sro77p (  Lehman et al., 1999  ;   Wirtz-Peitz 
and Knoblich, 2006  ). A structural study of tomosyn indicated 
that the C-terminal VAMP-like domain (VLD) of tomosyn acts 
as a SNARE domain that competes with VAMP-2, leading to 
inhibition of the formation of the SNARE complex (  Pobbati 
et al., 2004  ). We previously showed that tomosyn is directly 
phosphorylated by cAMP-dependent protein kinase (PKA) and 
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bodies (Abs) against the respective proteins. These results indi-
cate that tomosyn defi  ciency does not affect the expression 
levels of SNARE proteins. 
  Enhanced synaptic transmission in 
tomosyn-deﬁ  cient mice 
  We characterized the tomosyn-defi  cient mice electrophysio-
logically. First, we examined the effi  cacy of synaptic transmission 
at hippocampal mossy fiber synapses by measuring input –
  output relationships of excitatory postsynaptic potentials 
(EPSPs). EPSPs were increased in tomosyn-defi  cient mice at 
all stimulus intensities tested (  Fig. 1 D  ), indicating that synap-
tic transmission was enhanced. Next, we examined presynaptic 
short-term plasticity by inducing paired-pulse facilitation 
(PPF) at mossy fi  ber synapses (  Fig. 1 E  ). PPF of tomosyn-
defi  cient mice was decreased at all interstimulus intervals tested, 
indicating that the probability of neurotransmitter release was 
increased in tomosyn-defi   cient mice. Finally, we examined 
long-term plasticity by inducing long-term potentiation (LTP; 
  Fig. 1, F and G  ). The magnitude of mossy fi  ber LTP in tomosyn-
defi  cient mice was reduced only during the fi  rst 20 min. The 
limitation of this reduction to the early stage of LTP in tomosyn-
defi  cient mice may indicate that mossy fi  ber LTP consists of 
two phases, only the early one of which is regulated by tomosyn. 
Collectively, these results indicate that the probability of neuro-
transmitter release in tomosyn-defi  cient mice is higher than 
that in wild-type mice, suggesting that tomosyn inhibits synaptic 
vesicle fusion in vivo. 
  Reduced formation of the oligomerized 
SNARE complex in the tomosyn-
deﬁ  cient brain 
  Because the tomosyn defi  ciency facilitated synaptic transmis-
sion, we examined whether the formation of the SNARE com-
plex was affected by tomosyn defi  ciency. For this purpose, we 
took advantage of the fact that the assembled SNARE com-
plex is resistant to an SDS sample buffer at RT (  Hayashi et al., 
1994  ). Brain lysates from tomosyn-defi  cient and wild-type 
mice were solubilized in the SDS sample buffer and subjected 
to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 
and anti – SNAP-25 mAbs. Because tomosyn was known to in-
hibit the formation of the SNARE complex by competing with 
VAMP-2 ( Fujita et al., 1998 ;  Pobbati et al., 2004 ), we expected 
that the formation of the SNARE complex would be in-
creased in tomosyn-defi  cient mice. Unexpectedly, the amount 
of the assembled SNARE complex in tomosyn-deficient 
mice was reduced compared with wild-type mice (  Fig. 2 A  ). 
The molecular mass of the immunoblot band was apparently 
larger (    110 kD) than that of the expected single ternary 
SNARE complex (    50 kD). Because a previous study has 
suggested that the single ternary SNARE complex can form 
an oligomeric structure and exists as a star-shaped particle 
with three to four bundles in vivo (  Rickman et al., 2005  ), we 
assumed that the higher molecular mass bands might repre-
sent an oligomerized SNARE complex. Glycerol density 
gradient ultracentrifugation confi  rmed that the higher molec-
ular mass bands sedimented in fractions with the mass of the 
that this reduces its interaction with syntaxin-1 and enhances 
the formation of the SNARE complex (  Baba et al., 2005  ). In ad-
dition, Rho-associated serine/threonine kinase activated by Rho 
small G protein phosphorylates syntaxin-1, thereby increasing 
the affi  nity of syntaxin-1 for tomosyn and the formation of a 
stable complex between the two, resulting in inhibition of the 
formation of the SNARE complex during neurite extension 
(  Sakisaka et al., 2004  ). Recent genetic studies in   Caenorhabditis 
elegans   showed that TOM-1, an orthologue of vertebrate tomo-
syn, inhibits the priming of synaptic vesicles and that this prim-
ing is modulated by the balance between TOM-1 and UNC-13 
(  Gracheva et al., 2006  ;   McEwen et al., 2006  ). The large 
N-terminal WD-40 repeat domain of tomosyn was shown to be 
involved in the inhibitory role of tomosyn on exocytosis of dense 
core granules in adrenal chromaffi  n and PC12 cells (  Constable 
et al., 2005  ;   Yizhar et al., 2007  ). Thus, evidence is accumulating 
that tomosyn acts as a negative regulator for the formation of 
the SNARE complex, thereby inhibiting various vesicle fusion 
events. However, the precise molecular mechanism underlying 
the inhibitory action of the large N-terminal WD-40 repeat do-
main of tomosyn has yet to be elucidated. 
  In this study, we show that tomosyn catalyzes oligomer-
ization of the SNARE complex upon the direct interactions 
of the WD-40 repeat domain with SNAP-25 and syntaxin-1. 
Tomosyn inhibits SNARE-dependent synaptic vesicle fusion 
via both N-terminal WD-40 repeat domain  –  mediated oligomeriza-
tion of the SNARE complex and C-terminal VLD-based com-
petitive inhibition of SNARE complex formation, resulting in 
potent inhibition of neurotransmitter release. 
  Results 
  Generation of tomosyn-deﬁ  cient mice 
  To disrupt tomosyn in embryonic stem (ES) cells, gene target-
ing was used to replace the fi  rst coding exon and the 5     half of 
exon 2 with an MC1-neomycin resistance cassette (  Fig. 1 A  ). 
The targeting vector was electroporated into RW4 ES cells, and 
six G418-resistant colonies heterozygous for the tomosyn gene 
were selected. Cells from two independent ES clones were 
used to generate chimeric mice and successfully contributed to 
germline transmission. Tomosyn heterozygotes were inter-
crossed to produce homozygous mutant offspring (  Fig. 1 B  ). 
Mice homozygous for the disrupted allele expressed no intact 
tomosyn protein as analyzed by immunoblotting (  Fig. 1 C  ). 
The homozygous mice were born at a lower than expected fre-
quency, but born homozygous mice appeared healthy. How-
ever, when we attempted to generate C57B/6 backcrossed 
homozygous mice, homozygous mice backcrossed for more 
than three generations were not born, possibly because of a low 
fertilization rate in C57B/6 heterozygous mice (unpublished 
data). In this study, we used hybrid mice between C57B/6 and 
BDF1 mice because backcrossing to the C57B/6 genetic back-
ground had been unsuccessful. First, we examined the effect 
of tomosyn defi  ciency on the expression levels of SNARE 
proteins, including syntaxin-1, SNAP-25, VAMP-2, and com-
plexin. No signifi  cant changes were observed as estimated by 
immunoblotting of the homogenates of P20 cerebra with anti-325 OLIGOMERIZATION OF THE SNARE COMPLEX BY TOMOSYN   • Sakisaka et al. 
 We next examined whether the tomosyn defi  ciency affected 
the cellular localization of SNARE proteins. We immunostained 
the hippocampi of adult wild-type and tomosyn-defi  cient mice 
with anti  –  SNAP-25 mAb (SMI81), which is highly specifi  c for 
SNAP-25 and recognizes the SNAP-25 molecule incorporated 
into the SNARE complex (  Hu et al., 2002  ;   Rickman et al., 2005  ). 
oligomerized SNARE complex (  Fig. 2 B  ). Furthermore, the 
oligomerized SNARE complex was restored by the addition 
of recombinant maltose-binding protein (MBP)  –  tomosyn to 
brain extracts from tomosyn-defi  cient mice (  Fig. 2 A  , top). 
These results indicate that tomosyn enhances the oligomeriza-
tion of the SNARE complex. 
  Figure 1.       Properties of synaptic transmission and plasticity at hippocampal mossy ﬁ  ber synapses in tomosyn-deﬁ  cient mice.   (A) Targeted disruption of the 
tomosyn gene. A targeting vector was designed to remove the genomic DNA segment of exon 1, its upstream intron, and the 5     half of exon 2. The construct 
contained 4.5-kb 5    -ﬂ  anking DNA sequences and 2.8-kb 3    -ﬂ  anking DNA sequences. The diphtheria toxin DT-A cassette was inserted at the 3     end. In the 
targeted allele, the MC1-neo cassette replaces 1.1 kb of genomic DNA. Homologous recombination was veriﬁ  ed by using informative restriction fragments 
and diagnostic probes as indicated. (B) Southern hybridization using HindIII-digested DNA extracted from mouse tails and the 3     external probe shown 
in A. (C) Immunoblot analysis of the SNARE proteins extracted from the brains of wild-type or tomosyn-deﬁ  cient mice. (D) Input  –  output relationship of the 
EPSPs in wild-type (  n   = 11) and tomosyn-deﬁ  cient mice (  n   = 11). (E) PPF induced by paired-pulse stimulation at various interstimulus intervals in wild-type 
(  n   = 10) and tomosyn-deﬁ  cient mice (  n   = 10). (F) The averaged time course of LTP in wild-type and tomosyn-deﬁ  cient mice. Tetanic stimulation (100 Hz for 
1 s) was applied at 0 min in the presence of 50   μ  M D-APV (  D  -2-amino-5-phosphovaleric acid). After the LTP experiment, 1   μ  M DCG-IV (2S,2  ’  R,3  ’  R)-2-(2  ’  ,3  ’  -
dicarboxycyclopropyl)glycine), a group II metabotropic glutamate receptor agonist, was routinely applied to conﬁ  rm that the recorded EPSP originated 
mostly at the mossy ﬁ  ber synapses. If the amplitude of the residual EPSP was   >  15% of that of the original EPSP, the data were discarded. The dashed line 
indicates the normalized baseline excitatory postsynaptic potentials amplitude before tetanic stimulation. (G) Summary of LTP calculated as the percent 
increase in mean EPSP amplitude from 50  –  60 min after tetanic stimulation in wild-type and tomosyn-deﬁ  cient mice. KO, knockout; n.s., not signiﬁ  cant; WT, 
wild type. (D  –  G) Error bars represent SEM.     JCB • VOLUME 183 • NUMBER 2 • 2008  326
  Figure 2.       Tomosyn-enhanced oligomerization of the SNARE complex in vivo.   (A) Immunoblot analysis of the oligomerized SNARE complex from the brains 
of wild-type or tomosyn-deﬁ  cient mice. Extracts of brains from wild-type and tomosyn-deﬁ  cient mice were incubated with or without MBP-tomosyn for 16 h. 
Each sample was solubilized in the SDS sample buffer at RT or with boiling and subjected to SDS-PAGE followed by immunoblotting. Top, immunoblotting 
with anti  –  syntaxin-1 mAb; bottom, immunoblotting with anti  –  SNAP-25 mAb. Quantiﬁ  cation of the relative oligomerization of the SNARE complex is shown 
in the right panel. KO, knockout; WT, wild type. Error bar represents SD. (B) Glycerol density gradient ultracentrifugation of brain extracts from wild-type 
and tomosyn-deﬁ  cient mice. Extracts from wild-type and tomosyn-deﬁ  cient mice were subjected to 10  –  40% glycerol density gradient ultracentrifugation. 327 OLIGOMERIZATION OF THE SNARE COMPLEX BY TOMOSYN   • Sakisaka et al. 
oligomerized SNARE complex and the 50-kD band suggestive of 
the monomeric SNARE complex revealed that both bands were 
composed of syntaxin-1, SNAP-25, and VAMP-2 at a ratio of 
1:1:1, suggesting that the high molecular weight reaction product 
represents the oligomerized SNARE complex (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200805150/DC1). 
  Glycerol density gradient ultracentrifugation showed that 
the higher molecular mass bands observed after tomosyn treat-
ment sedimented as expected for a higher order SNARE com-
plex (  Fig. 3 B  ). The complexes generated by tomosyn migrated 
further than the monomeric SNARE complex, confi  rming that 
the oligomerized SNARE complexes are larger than the mono-
meric SNARE complex. The SNARE complexes can be visual-
ized by rotary shadowing electron microscopy as reported 
previously (  Hohl et al., 1998  ;   Rickman et al., 2005  ). The oligo-
merized SNARE complexes in fraction 11 were observed as 
star-shaped assemblies, whereas the monomeric SNARE com-
plexes in fraction 17 appeared as rodlike structures (  Fig. 3 C  ). 
We quantifi  ed the number of rods in the isolated oligomerized 
SNARE complexes. The particles bearing between two and four 
rods were observed in nearly 90% of total particles (  Fig. 3 C  ). 
Collectively, these results indicate that tomosyn has an ability to 
enhance oligomerization of the SNARE complex in vitro. 
  Requirement of the intact conﬁ  guration 
of SNAP-25 for the tomosyn action 
  It is well known that the SNARE complex is artifi  cially cross-
linked in vitro by oxidation of free cysteines on the hinge region 
of SNAP-25. Indeed, it was reported that the SNARE complex 
oligomer induced by complexin, which was originally reported by 
  Tokumaru et al. (2001)  , was an oxidative artifact (  Pabst et al., 
2002  ). To avoid this artifi  cial oxidation, we reacted the SNARE 
proteins and tomosyn under reducing conditions (1 mM DTT) in 
all in vitro assays, and reaction products were solubilized with the 
SDS sample buffer supplemented with a high concentration of a 
reducing reagent (75 mM DTT) before SDS-PAGE analysis. 
In addition, we reacted the SNARE proteins and tomosyn in the 
presence of TCEP (tris(2-carboxyethyl)phosphine), a stable re-
ducing reagent, as described previously (  Dai et al., 2007  ). Tomo-
syn enhanced the oligomerization of the SNARE complex even in 
the presence of 0.5 mM TCEP (Fig. S2 A, available at http://www
.jcb.org/cgi/content/full/jcb.200805150/DC1), suggesting that the 
oligomerization of the SNARE complex was not simply caused 
by artifi  cial oxidation. Next, we compared the activity of tomosyn 
to enhance the oligomerization of the SNARE complex with that 
of complexin. Consistent with a previous study ( Pabst et al., 2002 ), 
complexin did not enhance the oligomerization of the SNARE 
complex under reducing conditions (Fig. S2 B). In contrast, tomo-
syn enhanced the oligomerization of the SNARE complex in a 
The immunoreactivity for SNAP-25 was prominently reduced in 
the tomosyn-defi  cient brain in comparison with the wild-type 
brain (  Fig. 2 C  ). The most intense immunoreactivity for tomosyn 
was observed at the stratum lucidum of the CA3 area of the hippo-
campus in the wild-type brain, where the synapses between the 
mossy fi  ber terminals and dendrites of pyramidal cells localize. 
Immunoreactivity for SNAP-25 was also observed at the stra-
tum lucidum of the CA3 area in the wild-type brain. Only faint 
colocalization of SNAP-25 with tomosyn was observed there. 
We further assessed the localization of the SNARE proteins bio-
chemically. Recent studies have revealed that a subpopulation of 
SNAP-25 associates with lipid raft microdomains (  Sala  ü  n et al., 
2005  ;   Puri and Roche, 2006  ). In wild-type mice, SNAP-25 was 
concentrated in both raft and nonraft fractions (  Fig. 2 D  ), consis-
tent with the previous studies (  Sala  ü  n et al., 2005  ;   Puri and 
Roche, 2006  ). However, tomosyn was predominantly detected in 
the nonraft fractions. This distinct distribution supports the faint 
colocalization of SNAP-25 with tomosyn on the immunostained 
brain sections. In tomosyn-defi  cient mice, the concentrations 
of SNAP-25 in raft and nonraft fractions were weakened, 
and SNAP-25 was diffusely distributed throughout all fractions. 
The distribution of syntaxin-1 was not affected by tomosyn defi  -
ciency. These results suggest that tomosyn regulates the concen-
tration of SNAP-25 in lipid raft microdomains. The decreased 
immunostaining intensity for SNAP-25 is explained by the de-
creased formation of the oligomerized SNARE complex and the 
diffuse localization of SNAP-25 on the synaptic membrane in 
tomosyn-defi  cient mice. 
  Tomosyn-enhanced oligomerization of the 
SNARE complex in vitro 
  Next, we examined the ability of tomosyn to either enhance the 
formation of the SNARE complex or the oligomerization of the 
SNARE complex in a cell-free assay system using recombi-
nant proteins. Recombinant MBP-tomosyn was incubated with 
syntaxin-1 lacking the transmembrane domain (referred to as 
syntaxin-1 hereafter), SNAP-25, and VAMP-2 lacking the trans-
membrane (referred to as VAMP-2 hereafter) for 12 h under re-
ducing conditions. The reaction was terminated by the addition of 
the SDS sample buffer at RT, and each sample was subjected to 
SDS-PAGE followed by immunoblotting. The recombinant to-
mosyn protein shifted a 50-kD immunoreactive band to molecular 
masses of 90 and 130 kD in a dose-dependent manner (  Fig. 3 A  ), 
suggesting that tomosyn enhanced the oligomerization of the 
SNARE complex. An intense band for MBP-tomosyn was de-
tected at a higher molecular mass than the oligomerized SNARE 
complex, indicating that tomosyn was not incorporated into the 
SDS-resistant oligomerized SNARE complex. Characterization 
of the proteins extracted from the 130-kD band suggestive of the 
An aliquot of each fraction was solubilized in the SDS sample buffer at RT and subjected to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 
mAb. (C) Localization of SNAP-25 in the hippocampal CA3 region in wild-type and tomosyn-deﬁ  cient mice. Adult mouse hippocampal sections were 
doubly stained with antitomosyn pAb and anti  –  SNAP-25 (SMI81) mAb. The results shown are representative of three independent experiments. SL, stratum 
lucidum; SO, stratum oriens; SP, stratum pyramidale; SR, stratum radiatum. Bars, 30   μ  m. (D) Localization of the SNARE proteins in the lipid raft fraction. The 
CSM fractions from wild-type and tomosyn-deﬁ  cient mice were solubilized with Lubrol WX, and the lipid raft  –  enriched fractions were separated by sucrose 
gradient centrifugation as described previously (  Vetrivel et al., 2004  ). Each fraction was boiled in the SDS sample buffer and subjected to SDS-PAGE fol-
lowed by immunoblotting. Flotillin-2 was used as a lipid raft marker. Quantiﬁ  cation of the amount of protein in each fraction is shown in the right panel.     
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as the SNARE domain and thereby competes with VAMP-2 in 
the formation of the SNARE complex (  Pobbati et al., 2004  ). 
However, this competing activity of the VLD does not explain 
the activity of tomosyn to enhance the oligomerization of the 
SNARE complex. Therefore, we further characterized the pos-
sible interaction of tomosyn with the SNARE proteins. We fi  rst 
made an MBP-fused VLD (MBP-VLD;   Fig. 4 A  ) and examined 
the interaction between the MBP-VLD and SNARE proteins. 
Syntaxin-1 and SNAP-25 bound to MBP-VLD as previously re-
ported (  Fig. 4 B  ;   Yokoyama et al., 1999  ). VAMP-2 did not bind to 
MBP-VLD. Syntaxin-1 and SNAP-25 each enhanced the binding 
of the other to MBP-VLD by threefold, presumably refl  ecting 
the formation of a SNARE complex  –  like structure. VAMP-2 did 
not affect the binding of syntaxin-1 and SNAP-25 to MBP-VLD. 
We next made a VLD-defi  cient mutant of tomosyn (tomosyn-
    VLD) as an MBP fusion protein and examined the interac-
tion between MBP-tomosyn-  VLD and the SNARE proteins. 
Syntaxin-1 or SNAP-25 bound to MBP-tomosyn-  VLD ( Fig. 4 C ); 
however, VAMP-2 did not bind to MBP-tomosyn-   VLD. 
dose-dependent manner. Furthermore, we reacted the N-terminal 
portion of SNAP-25 (residues 1  –  95), the C-terminal portion of 
SNAP-25 encompassing the cysteine-rich hinge region (residues 
96  –  206), syntaxin-1, and VAMP-2 under reducing conditions in 
the presence of various amounts of MBP-tomosyn. The high mo-
lecular weight SNARE complexes indicative of the oligomerized 
SNARE complex were not formed in these reactions with divided 
SNAP-25 molecules (Fig. S2 C). These results indicate that the 
tomosyn-enhanced oligomerization of the SNARE complexes is 
not an artifact caused by oxidative cross-linking of SNAP-25 and 
that the intact structure of SNAP-25 is essential for the oligomer-
ization of the SNARE complex. 
  Different afﬁ  nities for SNAP-25 and 
syntaxin-1 between the N-terminal WD-40 
repeat domain and the C-terminal VLD 
  Tomosyn has at least two domains: an N-terminal WD-40 re-
peat domain and a C-terminal VLD (  Fujita et al., 1998  ). It has 
been shown that the VLD binds syntaxin-1 in the same manner 
  Figure 3.       Tomosyn-enhanced oligomerization 
of the SNARE complex in vitro.   (A) Reconstitu-
tion of tomosyn-induced oligomerization of the 
SNARE complex. Syntaxin-1, SNAP-25, and 
VAMP-2 were incubated in the presence or ab-
sence of the indicated amounts of MBP-tomo-
syn for 12 h under reducing conditions (1 mM 
DTT). The proteins were solubilized in the SDS 
sample buffer at RT and subjected to SDS-PAGE 
followed by immunoblotting with anti  –  syntaxin-1, 
anti  –  VAMP-2, or anti  –  SNAP-25 mAbs or anti-
MBP pAb. (B) Analysis of molecular mass of the 
oligomerized SNARE complex by density gradi-
ent ultracentrifugation. Syntaxin-1, SNAP-25, 
and VAMP-2 were incubated in the presence 
of MBP-tomosyn for 12 h. The sample was 
subjected to a 10  –  30% glycerol density gra-
dient. Aliquots of each gradient fraction were 
solubilized in the SDS sample buffer at RT and 
subjected to SDS-PAGE followed by immuno-
blotting with anti  –  syntaxin-1 mAb. (C) Mor-
phology of the oligomerized SNARE complex. 
Rotary shadowing electron micrographs of the 
SNARE complexes recovered in gradient frac-
tions 11 and 17. Quantiﬁ  cation of the number 
of legs in the SNARE complex is shown in the 
right panel. The results shown are representa-
tive of three independent experiments.     329 OLIGOMERIZATION OF THE SNARE COMPLEX BY TOMOSYN   • Sakisaka et al. 
It was shown that the VLD interacts with syntaxin-1 in a manner 
competitive with VAMP-2, forms the tomosyn complex, and 
down-regulates the formation of the SNARE complex (  Fujita 
et al., 1998 ;  Yokoyama et al., 1999 ;  Hatsuzawa et al., 2003 ;  Pobbati 
et al., 2004  ;   Sakisaka et al., 2004  ). Consistent with these studies, 
full-length MBP-tomosyn reduced the formation of the monomeric 
SNARE complex compared with tomosyn-    VLD at earlier time 
points ( Fig. 5 D ). These results indicate that the N-terminal WD-40 
repeat domain of tomosyn is suffi  cient for the oligomerization of 
the SNARE complex and that the VLD is dispensable. 
  We used syntaxin-1 lacking the transmembrane domain 
(syntaxin-1 –    TM) and VAMP-2 lacking the transmembrane 
domain  (VAMP-2 –    TM) for all of the aforementioned in vitro 
assays. Next, we tested whether tomosyn enhanced the oligo-
merization of SNARE complexes containing full-length syntaxin-1 
and full-length VAMP-2. Full-length syntaxin-1, SNAP-25, 
and full-length VAMP-2 were incubated in the presence 
or absence of MBP-tomosyn-   VLD.  Tomosyn-  VLD  enhanced 
the oligomerization of SNARE complexes composed of full-
length syntaxin-1, SNAP-25, and VAMP-2 (Fig. S3 A, available 
at http://www.jcb.org/cgi/content/full/jcb.200805150/DC1). 
Visualization of the samples by rotary shadowing electron 
microscopy indicated that tomosyn enhanced the formation 
of star-shaped assemblies of SNARE complexes (Fig. S3 B). 
We also observed that the reaction of full-length syntaxin-1, 
SNAP-25, and VAMP-2 predominantly led to formation of oligo-
merized SNARE complexes by themselves, whereas the reaction 
of syntaxin-1  –      TM, full-length SNAP-25, and VAMP-2  –     TM 
predominantly led to formation of the monomeric SNARE 
Neither syntaxin-1 nor SNAP-25 enhanced the binding of the 
other to MBP-tomosyn-    VLD. VAMP-2 decreased the binding 
of syntaxin-1 and SNAP-25 to MBP-tomosyn-    VLD and in-
duced the oligomerization of the SNARE complex (  Fig. 4 D  ). 
These results indicate that the large N-terminal WD-40 repeat 
domain of tomosyn and the C-terminal VLD have different af-
fi  nities for syntaxin-1 and SNAP-25. 
  Involvement of the N-terminal 
WD-40 repeat domain of tomosyn in the 
oligomerization of the SNARE complex 
  The aforementioned results prompted us to examine whether the 
N-terminal WD-40 repeat domain of tomosyn is involved in the 
enhanced oligomerization of the SNARE complex. We fi  rst pre-
incubated full-length MBP-tomosyn or MBP-tomosyn-   VLD 
with syntaxin-1 and SNAP-25 under reducing conditions ( Fig. 5 A ) 
and added VAMP-2 to this mixture for 1 h. The reaction was ter-
minated by addition of the SDS sample buffer at RT, and each 
sample was subjected to SDS-PAGE followed by immunoblotting 
with anti  –  syntaxin-1 mAb. Tomosyn-    VLD enhanced the oligo-
merization of the SNARE complex more potently than full-length 
MBP-tomosyn in a dose-dependent manner (  Fig. 5 B  ). We next 
examined the kinetics of the tomosyn-induced oligomerization of 
the SNARE complex. We fi  rst preincubated full-length MBP-to-
mosyn or MBP-tomosyn-    VLD with syntaxin-1 and SNAP-25 
under reducing conditions and added VAMP-2 to this mixture 
for the indicated periods of time. Tomosyn-    VLD enhanced the 
oligomerization of the SNARE complex more potently than 
full-length MBP-tomosyn in a time-dependent manner ( Fig. 5 C ). 
  Figure 4.       Different afﬁ  nities for SNAP-25 and 
syntaxin-1 between the N-terminal WD-40 
repeat domain and the C-terminal VLD.   (A) Mo-
lecular structures of tomosyn-    VLD and VLD. 
(B) Binding of syntaxin-1 and SNAP-25 to the 
VLD of tomosyn. Quantiﬁ  cation of the amount 
of syntaxin-1 bound to VLD is shown in the right 
panel. No binding of syntaxin-1 and SNAP-25 
to MBP was shown in the middle panel (neg-
ative control). (C) Binding of syntaxin-1 and 
SNAP-25 to MBP-tomosyn-    VLD. Quantiﬁ  ca-
tion of the amount of syntaxin-1 bound to MBP-
tomosyn-    VLD is shown in the right panel. For 
B and C, syntaxin-1, SNAP-25, or the mixture 
of syntaxin-1 and SNAP-25 were incubated 
with the indicated MBP-fusion protein immo-
bilized on amylose beads in the presence or 
absence of VAMP-2. After the beads were ex-
tensively washed, proteins bound to the beads 
were solubilized in the SDS sample buffer with 
boiling. The bound proteins were subjected to 
SDS-PAGE followed by immunoblotting with 
anti  –  syntaxin-1 mAb, anti  –  SNAP-25 mAb, or 
anti  –  VAMP-2 mAb. (B and C) Error bars rep-
resent SD. (D) Formation of the oligomerized 
SNARE complex in the supernatant fraction 
of the MBP-tomosyn-    VLD beads. Syntaxin-1, 
SNAP-25, and VAMP-2 were incubated with 
MBP-tomosyn-    VLD immobilized on amylose 
beads for the indicated periods of time. After 
centrifugation, the proteins in the super-
natant fraction were soIubilized in the SDS 
sample buffer at RT and subjected to SDS-
PAGE followed by immunoblotting with anti  –
  syntaxin-1 mAb.     JCB • VOLUME 183 • NUMBER 2 • 2008  330
was composed of these molecules at a ratio of 1:1:1 (Fig. S3 C, 
right). Therefore, these results indicate that the transmem-
brane domains of syntaxin-1 and VAMP-2 have the ability to 
complex   (  compare Fig. S1 A with Fig. S3 C, left). Character-
ization of the reaction products of full-length syntaxin-1, SNAP-25, 
and VAMP-2 showed that the oligomerized SNARE complex 
  Figure 5.       Involvement of the N-terminal WD-40 
repeat domain of tomosyn in the oligomerization of 
the SNARE complex.   (A) Molecular structures of tomo-
syn and tomosyn-    VLD. (B) Dose-dependent effect of 
tomosyn on the oligomerization of the SNARE com-
plex. Syntaxin-1 and SNAP-25 were incubated in the 
presence of the indicated amounts of MBP-tomosyn 
or MBP-tomosyn-    VLD for 12 h. Each mixture was 
further incubated with VAMP-2 for 1 h. The proteins 
were solubilized in the SDS sample buffer at RT and 
subjected to SDS-PAGE followed by immunoblotting 
with anti  –  syntaxin-1 mAb. Quantiﬁ  cation of the rela-
tive oligomerization of the SNARE complex is shown 
in the bottom panel. (C) Time-dependent effect of to-
mosyn on the oligomerization of the SNARE complex. 
Syntaxin-1 and SNAP-25 were incubated in the pres-
ence of MBP-tomosyn or MBP-tomosyn-    VLD for 12 h. 
Each mixture was further incubated with VAMP-2 
for the indicated periods of time. The proteins were 
solubilized in the SDS sample buffer at RT and sub-
jected to SDS-PAGE followed by immunoblotting with 
anti  –  syntaxin-1 mAb. Quantiﬁ   cation of the relative 
oligomerization of the SNARE complex is shown in 
the bottom panel. (D) Difference in the formation of the 
ternary SNARE complex between MBP-tomosyn and 
MBP-tomosyn-    VLD. Short exposure of the ﬁ  lm in C to 
detect the monomeric SNARE complex. Quantiﬁ  cation 
of the relative formation of the ternary SNARE com-
plex is shown in the bottom panel. The results shown 
are representative of three independent experiments. 
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tomosyn. These results also suggest that although tomosyn nega-
tively regulates formation of the ternary SNARE complex via the 
C-terminal VLD and positively regulates the oligomerization of 
the SNARE complex via the large N-terminal WD-40 repeat do-
main, the actions of the C-terminal VLD and the large N-terminal 
WD-40 repeat domain are mutually exclusive. 
  We previously reported that tomosyn is phosphorylated by 
PKA, leading to a decrease in its binding activity for VAMP-2 
( Baba et al., 2005 ). Therefore, we examined whether the phosphoryl-
ation of tomosyn altered its activity to enhance the oligomerization 
of the SNARE complex. Syntaxin-1, SNAP-25, and VAMP-2 were 
reacted in the presence of either the PKA-phosphorylated form or 
nonphosphorylated form of tomosyn. The phosphorylated form of 
tomosyn enhanced the tomosyn-induced oligomerization of the 
SNARE complex more effi  ciently than the nonphosphorylated 
form (Fig. S5 A, available at http://www.jcb.org/cgi/content/full/
jcb.200805150/DC1), suggesting that the activity of the WD-40 
repeat domain to enhance the oligomerization of the SNARE com-
plex is regulated by PKA-catalyzed phosphorylation. 
  Functional signiﬁ  cance of the N-terminal 
WD-40 repeat domain of tomosyn for 
neurotransmitter release 
  To further confi  rm the functional signifi  cance of the N-terminal 
WD-40 repeat domain of tomosyn for neurotransmitter release, 
we used a synapse formed between superior cervical ganglion 
(SCG) neurons in culture (  Ma and Mochida, 2007  ). First, we de-
termined the precise binding site of tomosyn. The large N-terminal 
WD-40 repeat domain of tomosyn was divided into three 
fragments: fragment 1 (Frg. 1), which contained the fi  rst fi  ve 
WD-40 repeats, Frg. 2, which contained the second two WD-40 
repeats, and Frg. 3, comprising the C-terminal region with no 
WD-40 repeats (  Fig. 7 A  ). The fragments were expressed as 
MBP-fused proteins in   Escherichia coli  , immobilized on amy-
lose resin, and reacted with the SNARE proteins. Frgs. 1 and 2, 
but not Frg. 3, bound syntaxin-1 (  Fig. 7 B  ). Indeed, SNAP-25 
bound the same WD-40 repeat domain encompassing Frgs. 1 and 2 
as syntaxin-1 (Fig. S5 B). Next, we examined which domains 
were responsible for the oligomerization of the SNARE com-
plex. Frgs. 1 and 2, but not Frg. 3, enhanced the oligomerization 
of the SNARE complex, in agreement with their affi  nity to syn-
taxin-1 (  Fig. 7 C  ). These results indicate that the WD-40 repeat 
domains are responsible for the oligomerization of the SNARE 
complex. We injected the MBP-fused fragments of tomosyn into 
presynaptic cell bodies by microinjection and recorded EPSPs 
evoked by action potentials in the presynaptic neurons (  Fig. 7, 
D  –  F  ). Injection of Frgs. 1 and 2 reduced EPSPs. In contrast, in-
jection of Frg. 3 did not affect EPSPs. These results provide fur-
ther evidence suggesting that tomosyn-enhanced oligomerization 
of the SNARE complex inhibits neurotransmitter release. 
Consistent with a previous study (  Pobbati et al., 2004  ), we ob-
served that the VLD inhibits the formation of the monomeric 
SNARE complex and that injection of the VLD into SCG neu-
rons reduces EPSPs. VLD-injected neurons restored the reduced 
EPSPs faster than Frg. 1  –   and Frg. 2  –  injected neurons, indicating 
that Frgs. 1 and 2 inhibited neurotransmitter release more potently 
than the VLD. The sustained reduction of EPSPs in Frg. 1  –   and 
facilitate the oligomerization of the SNARE complexes and 
that the WD-40 repeat domain of tomosyn enhances the oligo-
merization of the SNARE complex independently of the trans-
membrane domains of syntaxin-1 and VAMP-2. These results 
provide an explanation of our observation that the oligomerized 
SNARE complex, but not the monomeric complex, was detected 
in brain lysates from mouse brain (  Fig. 2 A  ), although the mo-
nomeric SNARE complex was readily detected among the in vi-
tro reaction products of syntaxin-1  –      TM, full-length SNAP-25, 
and VAMP-2 –   TM. 
  We further characterized the nature of the tomosyn-
enhanced oligomerization of the SNARE complex. First, we 
titrated the SNARE proteins. Various amounts of the SNARE 
proteins were reacted in the absence or presence of MBP-
tomosyn-    VLD (Fig. S4 A, available at http://www.jcb.org/
cgi/content/full/jcb.200805150/DC1). The SNARE proteins 
formed the oligomerized SNARE complex in a dose-dependent 
manner, indicating that a higher amount of the monomeric SNARE 
complexes assembles as oligomers in a tomosyn-independent 
manner. The reactions in the presence of MBP-tomosyn-   VLD 
moderately enhanced the formation of the monomeric SNARE 
complex and dramatically enhanced the formation of the oligo-
merized SNARE complex at all concentrations of the SNARE 
proteins tested. Next, we examined whether tomosyn oligomer-
izes preassembled SNARE complexes. The SNARE proteins 
were fully reacted in advance, and the formed SNARE com-
plexes (preassembled SNARE complexes) were reacted with 
MBP-tomosyn-    VLD (Fig. S4 B). MBP-tomosyn-   VLD  en-
hanced oligomerization of the SNARE complex. Collectively, 
these results suggest that tomosyn achieves the oligomerization 
of the SNARE complex via both facilitation of the formation of 
the monomeric SNARE complex and enhancement of the oligo-
merization of the preassembled SNARE complex. 
  Regulation of N-terminal WD-40 repeat 
domain  –  induced oligomerization of the 
SNARE complex by the C-terminal VLD 
  We examined the effect of the VLD on large N-terminal WD-40 
repeat domain – induced oligomerization of the SNARE complex. 
We fi rst preincubated MBP-tomosyn-    VLD with syntaxin-1 and 
SNAP-25 in the presence of various amounts of MBP (control) 
or MBP-VLD (  Fig. 6 A  ) and added VAMP-2 to this mixture for 
1 h. The reaction was terminated by the addition of the SDS 
sample buffer at RT, and each sample was subjected to SDS-
PAGE followed by immunoblotting with anti  –  syntaxin-1 mAb. 
MBP-VLD potently inhibited the formation of the ternary 
SNARE complex and the oligomerization of the SNARE com-
plex in a dose-dependent manner (  Fig. 6 B  ). Next, we examined 
the kinetics of the inhibitory effect of MBP-VLD on the N-terminal 
domain  –  induced oligomerization of the SNARE complex. 
MBP-VLD potently inhibited the formation of the ternary 
SNARE complex and the oligomerization of the SNARE com-
plex in a time-dependent manner (  Fig. 6 C  ). These results indi-
cate that the C-terminal VLD of tomosyn inhibits the formation 
of the ternary SNARE complex and thereby suppresses the oligo-
merization of the SNARE complex, which was basally induced 
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  Figure 6.       Regulation of the N-terminal WD-40 repeat domain  –  induced oligomerization of the SNARE complex by the C-terminal VLD.   (A) Molecular 
structures of tomosyn-    VLD and VLD. (B) Dose-dependent inhibitory effect of the VLD on the tomosyn-    VLD  –  induced oligomerization of the SNARE complex 
through inhibiting formation of the monomeric SNARE complex. Syntaxin-1, SNAP-25, and MBP-tomosyn-    VLD were incubated in the presence of the 
indicated amounts of MBP or MBP-VLD for 12 h. Each mixture was further incubated with VAMP-2 for 1 h. The proteins were solubilized in the SDS sample 
buffer at RT and subjected to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 mAb. (top left) Long exposure of the ﬁ  lm to detect the oligomer-
ized SNARE complex. (bottom left) Short exposure of the ﬁ  lm to detect the ternary SNARE complex. Quantiﬁ  cations of the relative oligomerization of the 
SNARE complex and the relative formation of the ternary SNARE complex are shown in the right panels. (C) Time-dependent inhibitory effect of the VLD on 
tomosyn-    VLD  –  induced oligomerization of the SNARE complex. Syntaxin-1, SNAP-25, and MBP-tomosyn-    VLD were incubated in the presence of MBP or 
MBP-VLD for 12 h. Each mixture was further incubated with VAMP-2 for the indicated periods of time. The proteins were solubilized in the SDS sample buffer 
at RT and subjected to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 mAb. Quantiﬁ  cation of the relative oligomerization of SNARE complex 
is shown in the bottom panel. The results shown are representative of three independent experiments. (B and C) Error bars represent SD.     333 OLIGOMERIZATION OF THE SNARE COMPLEX BY TOMOSYN   • Sakisaka et al. 
  Figure 7.       Functional correlation of the WD-40 repeat domain  –  enhanced oligomerization of the SNARE complex with inhibition of neurotransmitter release.   
(A) Molecular structures of tomosyn fragments. (B) Binding of the tomosyn fragments to syntaxin-1. MBP-fused fragments of tomosyn were immobilized on 
amylose resin and incubated with recombinant SNARE proteins. The samples were subjected to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 
mAb. (C) The tomosyn fragments responsible for the oligomerization of the SNARE complex. The SNARE proteins were reacted in the presence of various 
amounts of the tomosyn fragment, and samples were soIubilized in the SDS sample buffer at RT and subjected to SDS-PAGE followed by immunoblotting 
with anti  –  syntaxin-1 mAb. (D) Inhibitory effects of the truncated forms of the WD-40 repeat domain on synaptic transmission between SCG neurons. The 
MBP-tomosyn fragment was injected into the presynaptic neurons at t = 0 (100   μ  M in the pipette). EPSP amplitudes measured every 10 s were normalized 
and averaged (  n   = 4  –  9). The mean values smoothed by an eight-point moving average algorithm are plotted. (E) Smoothed mean values shown in D were 
plotted with lines. (F) Decrease in EPSP amplitudes induced by various MBP-tomosyn fragments are shown in graphs in D. Each bar shows the smoothed 
mean values of the EPSP amplitudes at 20 min after injection. *, P   <   0.01, unpaired   t   test; Frg. 3 injection versus Frg. 1, Frg. 2, or VLD injection. Error 
bars represent SEM.     JCB • VOLUME 183 • NUMBER 2 • 2008  334
    20  –  30 min, and this resembled the short-term potentiation 
that is absent in the tomosyn-defi  cient mice. Thus, mossy fi  -
ber LTP is quite likely to be mediated by two different mech-
anisms, one of which is dependent on tomosyn and short 
lasting and the other of which is independent of tomosyn and 
long lasting. 
  The activity of the WD-40 repeat domain to catalyze the 
oligomerization of the SNARE complex was repressed by 
the C-terminal VLD, suggesting that the catalytic activity of the 
WD-40 repeat domain competes with C-terminal VLD-based 
inhibition of SNARE complex formation. Therefore, it is plau-
sible that these two inhibitory actions of tomosyn against the 
SNARE complexes are properly balanced in vivo. Indeed, we 
showed that PKA is one possible regulator of this balance. 
We previously reported that PKA phosphorylates tomosyn, result-
ing in decreased affi  nity of the C-terminal VLD for syntaxin-1 
(  Baba et al., 2005  ). The PKA-catalyzed phosphorylation of 
tomosyn increases the fusion-competent readily releasable 
pool of synaptic vesicles and thereby enhances neurotransmit-
ter release in SCG neurons. In this study, we demonstrated 
that the PKA-phosphorylated form of tomosyn enhances the 
oligomerization of the SNARE complex more effi  ciently than 
the nonphosphorylated form, indicating that PKA regulates 
the activity of the WD-40 repeats domain to enhance the oligo-
merization of the SNARE complex and inhibits neurotrans-
mitter release. The present results are apparently inconsistent 
with our previous results, but the reason for this inconsistency 
is unknown. However, the PKA-catalyzed phosphorylation of 
tomosyn may be more important for balancing the activities of 
the WD-40 repeat domain and the C-terminal VLD than for 
altering the affi  nity of the C-terminal VLD for syntaxin-1. 
We previously showed that the major phosphorylation site of 
tomosyn, serine 724, is located at the linker region between 
the N-terminal WD-40 repeat domain and the C-terminal VLD 
(  Baba et al., 2005  ). The linker region may act as an intra-
molecular switch for tomosyn by balancing its two inhibitory 
effects on SNARE function. 
  The WD-40 repeat domain of tomosyn shares similarity 
to the   Drosophila   tumor suppressor D-Lgl, its mammalian ho-
mologues M-Lgl1 and M-Lgl2, and the yeast proteins Sro7p 
and Sro77p, which play important roles in polarized exocytosis 
by regulating SNARE function on the plasma membrane in 
  Drosophila   neuroblasts, mammalian epithelial cells, and yeast, 
respectively (  Wirtz-Peitz and Knoblich, 2006  ). A recent struc-
tural study of Sro7 suggested that the N-terminal WD-40 re-
peat domain of Sro7 interacts with Sec9, a yeast counterpart of 
SNAP-25, and that this interaction inhibits the formation of the 
monomeric SNARE complexes (  Hattendorf et al., 2007  ). These 
results are inconsistent with our present fi  nding that the inter-
action of the N-terminal WD-40 repeat domain of tomosyn 
with SNAP-25 did not inhibit the formation of the monomeric 
SNARE complexes. However, it remains unknown whether the 
WD-40 repeat domain of Sro7 catalyzes the oligomerization of 
the SNARE complex as tomosyn does. Further studies of the 
WD-40 repeat domains of M-Lgl1, M-Lgl2, Sro7, and Sro77 
will be needed to understand the conserved role of Lgl family 
proteins in the regulation of SNARE function. 
Frg. 2  –  injected neurons suggests that tomosyn-enhanced oligo-
merization of the SNARE complex potently inhibits neurotrans-
mitter release. 
  Discussion 
  In this study, we demonstrated that tomosyn regulates the oligo-
merization of the SNARE complex and inhibits SNARE-depen-
dent neurotransmitter release. We reconstituted tomosyn-induced 
oligomerization of the SNARE complex in vitro and showed that 
the WD-40 repeat domain of tomosyn has an intrinsic ability to 
catalyze the oligomerization of the SNARE complex. It was pre-
viously reported that the C-terminal VLD of tomosyn acts as a 
SNARE domain competing with VAMP-2 and thereby inhibiting 
the formation of the SNARE complex (  Yokoyama et al., 1999  ; 
  Pobbati et al., 2004  ). Consistent with these studies, our in vitro 
assay showed that the C-terminal VLD of tomosyn inhibits the 
formation of the SNARE complex. Therefore, we concluded that 
tomosyn potently inhibits SNARE-dependent synaptic vesicle 
fusion via both N-terminal WD-40 repeat domain  –  catalyzed 
oligomerization of the SNARE complex and C-terminal VLD-
based competitive inhibition of SNARE complex formation. 
 Synaptic  effi  cacy at mossy fi  ber synapses was enhanced 
in tomosyn-defi  cient mice, suggesting that tomosyn inhibits 
synaptic transmission in normal animals, most likely through 
regulation of the oligomerization of the SNARE complex. We 
also demonstrated that PPF was signifi  cantly smaller in tomo-
syn-defi  cient mice than in littermate wild-type mice. PPF is a 
physiological measure of the probability of neurotransmitter 
release from the presynaptic terminal; PPF increases when the 
probability is decreased but decreases when the probability is 
increased (  Manabe et al., 1993  ). Thus, the enhanced synaptic 
effi  cacy in the input  –  output relationship in tomosyn-defi  cient 
mice is most probably caused by increased probability of neuro-
transmitter release. Interestingly, there was no difference in 
the magnitude of mossy fi  ber LTP measured 50  –  60 min after 
tetanic stimulation, whereas short-term potentiation observed 
for     20 min after tetanic stimulation in tomosyn-defi  cient 
mice is smaller than that in littermate wild-type mice. These 
fi  ndings indicate that mossy fi  ber LTP is composed of at least 
two phases, and only the earlier potentiation is associated 
with tomosyn-mediated regulation of transmitter release, whereas 
expression of the later phase of LTP is not mediated by tomo-
syn. Because basal probability of neurotransmitter release is 
apparently different between wild-type and tomosyn-defi  cient 
mice but the magnitude of LTP at the late phase is not, the 
expression of mossy fi  ber LTP is likely to be independent of 
the initial probability of neurotransmitter release. It has been 
reported that mossy fi  ber LTP is mediated by cAMP and PKA 
(  Weisskopf et al., 1994  ). In this study, the authors found that 
forskolin, an activator of adenylate cyclase, and membrane-
permeable cAMP analogues potentiate mossy fi  ber EPSPs 
via the same mechanism underlying mossy fi  ber LTP induced 
by tetanic stimulation of mossy fi  bers; after potentiation by 
the application of these drugs, no long-lasting potentiation 
was induced by tetanic stimulation. However, short-term po-
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were soaked with the same ﬁ  xative at 4  °  C for 2 h. For cryoprotection, sec-
tions were placed into 20% sucrose solution for 2 h and 25% sucrose 
solution overnight. The sections were frozen using liquid nitrogen. Serial 
8-  μ  m-thick sections were cut in a cryostat. Each sample was incubated with 
antitomosyn pAb and anti  –  SNAP-25 mAb (SMI81) followed by incubation 
with secondary Alexa Fluor  –  conjugated secondary Abs. After being 
washed with PBS, they were embedded and viewed using a confocal laser-
scanning microscope (LSM 510-V3.2; Carl Zeiss, Inc.) with a 20 or 40  ×   
objective lens. Collected data were exported as 8-bit TIFF ﬁ  les and pro-
cessed using Photoshop (version 7.0; Adobe). 
  Electron microscopy 
  The sample was mixed with an equal volume of glycerol and sprayed on 
freshly cleaved pieces of mica according to a previously described method 
(  Tyler and Branton, 1980  ). After drying under 10 
    6   mbar for 15 min, each 
sample was rotary shadowed with platinum carbon at a shadowing angle 
of     5  °  . Shadowed ﬁ  lms were ﬂ  oated on water, picked up onto Formvar-
coated grids, and observed in an electron microscope (JEM-1010HC; JEOL) 
at an accelerating voltage of 100 kV. 
  Assay for the oligomerization of the SNARE complex 
  Recombinant syntaxin-1, SNAP-25, VAMP-2, and complexin-2 were puriﬁ  ed 
as GST-fusion proteins and cleaved with thrombin to remove GST. 1   μ  M 
syntaxin-1, 1   μ  M SNAP-25, and 0.1   μ  M MBP-tomosyn were incubated under 
reducing conditions (1 mM DTT) at 4  °  C for 12 h. The mixture was further in-
cubated with 1   μ  M VAMP-2 at 25  °  C for 1 h. The reaction was terminated by 
addition of the SDS sample buffer to give ﬁ  nal concentrations of 60 mM 
Tris/HCl, pH 6.8, 75 mM DTT, 20 mM EDTA, 5% glycerol, and 2% SDS and 
was further incubated at RT or 100  °  C for 5 min. Each sample was subjected 
to SDS-PAGE followed by immunoblotting with anti  –  syntaxin-1 mAb. 
  Isolation of the lipid raft fraction 
  The crude synaptic membrane (CSM) fraction was isolated from 12 mouse 
brains as described previously (  Mizoguchi et al., 1989  ), and the lipid raft 
fraction was separated from the CSM fraction as described previously 
(  Vetrivel et al., 2004  ). In brief, 2 mg of the CSM fraction was resuspended 
in TNE buffer (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA) 
containing 0.5% Lubrol WX at 4  °  C for 30 min, and 40% sucrose was 
added. A discontinuous sucrose gradient was made by layering 30% 
sucrose (3 ml), 25% sucrose (3 ml), and 5% sucrose (3 ml) onto the sample 
(2 ml), and the gradient was subjected to ultracentrifugation at 201,800   g   
for 2 h at 4  °  C. 11 1-ml fractions were collected from the top of the gradi-
ent, and an equal volume of each fraction was analyzed by immunoblot-
ting. The lipid raft fraction was determined by immunoblotting for ﬂ  otillin-2, 
a lipid raft  –  associated protein. 
  Assay for the binding of syntaxin-1 or SNAP-25 to tomosyn 
  Syntaxin-1, SNAP-25, the mixture of syntaxin-1 and SNAP-25, or the mix-
ture of syntaxin-1, SNAP-25, and VAMP-2 was incubated with MBP, MBP-
tomosyn-    VLD, or MBP-VLD immobilized on 50   μ  l of amylose beads in 
500   μ  l of buffer B (20 mM Tris/HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 
1 mM DTT, 5 mM MgCl  2  , and 0.5% NP-40) at 25  °  C for 1 h. After the beads 
had been extensively washed with buffer B, the bound proteins were solubi-
lized in the SDS sample buffer and further incubated at RT or 100  °  C for 
5 min. Each sample was subjected to SDS-PAGE followed by immunoblotting 
with anti  –  syntaxin-1 mAb, anti  –  SNAP-25 mAb, or anti  –  VAMP-2 mAb. The 
intensity of the immunoblot band was determined by densitometry. 
  Culture of SCG neurons 
  Postnatal day 7 Wistar ST rats were decapitated under diethyl ether anes-
thesia according to the guidelines of the Physiological Society of Japan. 
Isolated SCG neurons were maintained in culture for 5  –  6 wk as described 
previously (  Mochida et al., 1994  ;   Mochida, 1995  ). In brief, SCGs were 
dissected, desheathed, and incubated with 0.5 mg/ml collagenase 
(Worthington Biochemical) in L-15 (Invitrogen) at 37  °  C for 10 min. After 
enzyme digestion, semidissociated ganglia were triturated gently through 
small-pore glass pipettes until a cloudy suspension was observed. After 
washing by low speed centrifugation at 1,300 rpm for 3 min, the collected 
cells were plated onto coverslips in plastic dishes (35-mm diameter; ap-
proximately one ganglion per dish; Corning) containing a growth medium 
of 84% Eagle  ’  s minimal essential medium (Invitrogen), 10% fetal calf serum 
(Invitrogen), 5% horse serum (Invitrogen), 1% penicillin/streptomycin (Invit-
rogen), and 25 ng/ml nerve growth factor (2.5 S; grade II; Alomone Labo-
ratories). The cells were maintained at 37  °  C in a 95% air and 5% CO  2   
humidiﬁ  ed incubator, and the medium was changed twice per week. 
  Materials and methods 
  Recombinant proteins 
  Expression vectors for full-length rat medium-sized tomosyn (1  –  1,116 aa) 
and tomosyn-    VLD (1  –  949 aa) were constructed in pFastBac1-MBP using 
standard molecular biology methods. The pFastBac1-MBP vector was con-
structed from a baculovirus transfer vector, pFastBac1 (Invitrogen), to ex-
press a fusion protein with N-terminal MBP (  Yasumi et al., 2005  ). MBP-fused 
tomosyn and tomosyn-    VLD were expressed in Sf21 cells and puriﬁ  ed with 
amylose resin in accordance with the manufacturer  ’  s manual. A cDNA en-
coding the VLD domain (1,031  –  1,116 aa) of rat medium-sized tomosyn 
was subcloned into the pMAL-C2 vector (New England Biolabs, Inc.) to ex-
press a fusion protein with N-terminal MBP in bacteria. MBP-VLD was ex-
pressed in   E. coli   and puriﬁ  ed with amylose resin. For the expression of 
GST-fused syntaxin-1 (GST  –  syntaxin-1), GST-fused SNAP-25 (GST  –  SNAP-25), 
and GST-fused VAMP-2 (GST  –  VAMP-2), cDNAs encoding the cytoplas-
mic domain of syntaxin-1 (1  –  265 aa), full-length SNAP-25 (1  –  206 aa), 
and the cytoplasmic domain of VAMP-2 (1  –  94 aa) were subcloned into 
pGEX vectors (GE Healthcare). GST  –  syntaxin-1, GST  –  SNAP-25, and GS  –
  VAMP-2 were expressed in   E. coli   and puriﬁ  ed with glutathione  –  Sepharose 
4B (GE Healthcare) in accordance with the manufacturer  ’  s manual. To cut 
off the GST tags, GST  –  SNAP-25 was digested with PreScission protease 
(GE Healthcare), and GST  –  syntaxin-1 and GST  –  VAMP-2 were digested 
with thrombin. The GST tag and PreScission protease in SNAP-25 were re-
moved by glutathione  –  Sepharose 4B. The GST tags and thrombin in syn-
taxin-1 and VAMP-2 were removed by glutathione  –  Sepharose 4B and 
benzamidine Sepharose, respectively. Syntaxin-1 and VAMP-2 were further 
puriﬁ  ed using Mono-Q (GE Healthcare) and Mono-S columns (GE Health-
care), respectively, as previously described (  Fasshauer et al., 1997  ). 
  Abs 
  An antitomosyn pAb was prepared as described previously (  Fujita et al., 
1998  ). Anti  –  syntaxin-1 mAb (10H5) was provided by M. Takahashi (Kita-
sato University, Kanagawa, Japan). Anti  –  syntaxin-1 mAb, anti  –  VAMP-2 
mAb (Wako Chemicals USA, Inc.), anti  –  SNAP-25 mAb (SMI81; Abcam), 
anti  –  SNAP-25 mAb (Millipore), anticomplexin pAb (Synaptic Systems 
GmbH), and anti-MBP pAb (New England Biolabs, Inc.) were purchased 
from commercial sources. Alexa Fluor  –  conjugated secondary Abs (Invitro-
gen) were used to detect primary Abs in immunoﬂ  uorescence microscopy 
of brain sections. 
  Electrophysiology 
  Male mutant mice and their littermates (6  –  12 wk old) were used. Hippo-
campal slices (400-  μ  m thick) were cut with a tissue slicer (Vibratome) and 
placed in a humidiﬁ  ed interface-type holding chamber for at least 1 h. 
A single slice was transferred to the recording chamber and submerged 
in a continuously perfusing medium that had been saturated with 95% 
O  2  /5% CO  2  . The medium contained 119 mM NaCl, 2.5 mM KCl, 1.3 mM 
MgSO  4  , 2.5 mM CaCl  2  , 1 mM NaH  2  PO  4  , 26.2 mM NaHCO  3  , and 
11 mM glucose. All experiments were conducted at 25  –  26  °  C. Electrical 
stimuli were delivered through a tungsten bipolar electrode inserted into 
the stratum granulosum of the dentate gyrus, and the resulting ﬁ  eld EPSPs 
were recorded from the stratum lucidum in the CA3 region with a glass 
microelectrode ﬁ  lled with 3 M NaCl (1  –  2 M  Ω  ). PPF of excitatory synaptic 
transmission was induced by stimulating afferent ﬁ  bers at short intervals 
of 30, 50, 100, 300, and 500 ms. LTP of excitatory synaptic transmission 
was induced in the presence of 50   μ  M D-APV, an   N  -methyl-  D  -aspartate re-
ceptor antagonist, by applying tetanic stimulation (100 Hz for 1 s) to the 
mossy ﬁ  bers. All experiments were performed in a blind fashion. The sta-
tistical signiﬁ  cance of differences between the genotypes was determined 
by two-tailed   t   tests. 
  Glycerol gradient ultracentrifugation of the detergent extracts of mouse 
cerebral cortex 
  The detergent extracts of 500   μ  l of mouse cerebra (1.25 mg of protein) were 
layered onto 10.5-ml linear 10  –  40% glycerol gradients in buffer A (20 mM 
Tris/HCl, pH 7.5, 150 mM NaCl, 5 mM MgCl  2  , 1 mM EDTA, 1 mM DTT, 
10   μ  M     -phenylmethanesulfonyl ﬂ  uoride hydrochloride, 10   μ  g/ml leupeptin, 
10   μ  g/ml aprotinin, and 0.5% NP-40) and subjected to centrifugation at 
207,000   g   for 18 h. Fractions of 1 ml were collected. 
  Immunohistochemistry 
  Adult mice were deeply anesthetized by ether and perfused with freshly 
prepared 2% paraformaldehyde in PBS for 15 min. Brains were dissected 
out and cut with a razor into several 2-mm-thick coronal sections, which JCB • VOLUME 183 • NUMBER 2 • 2008  336
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  Synaptic transmission between SCG neurons 
  EPSP recording and injection of the recombinant proteins were performed 
as described previously (  Mochida et al., 1994  ,   1996  ). Electrophysiologi-
cal data collected using software written by the late L. Tauc (Centre Na-
tional de la Recherche Scientiﬁ  que, Gif-sur-Yvette, France) were analyzed 
with Origin (Microcal Software Inc.). For   Fig. 7 D  , the peak amplitudes of 
EPSP were averaged. The resultant values were smoothed by an eight-point 
moving average algorithm and plotted against recording time with t = 0 in-
dicating the presynaptic injection. For   Fig. 7 F  , data at 20 min after injec-
tion from each group were averaged, and statistical signiﬁ  cance  was 
determined by unpaired Student  ’  s   t   tests (vs. the Frg. 3  –  injected group). 
  Online supplemental material 
  Fig. S1 shows characterization of the high molecular weight SNARE com-
plex. Fig. S2 shows validation of tomosyn-enhanced oligomerization of the 
SNARE complex. Fig. S3 shows tomosyn-independent oligomerization of the 
SNARE complex facilitated by the transmembrane domains of the SNARE 
proteins. Fig. S4 shows characterization of the tomoysn-enhanced oligomer-
ization of the SNARE complex. Fig. S5 shows the effect of the PKA-catalyzed 
phosphorylation of tomosyn on the oligomerization of the SNARE complex 
and binding of SNAP-25 to the WD-40 repeat domain of tomosyn. 
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